USD 1.87 billion
Report ID:
SQMIG35H2055 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
119
|Figures:
78
Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.87 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.66 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).
A substance that is typically transparent to X-ray and is utilized in medical imaging to accelerate the contrast of fluids or structures is referred to as contrast media or contrast agent. For contrast ultrasound imaging, microbubbles are utilized as a blood pool agent in radiology and cardiology. Applications like gene therapy, drug delivery, molecular imaging, and stem cell delivery make extensive use of them.
Using ligand molecules that are restricted to disease-specific molecular markers, microbubbles can also function. The microbubble-based ultrasound contrast agents' primary functions include monitoring the biomarker condition of the vascular endothelium, imaging inflammation, observing the vasculature of tumors, and other tasks.
Microbubbles are injected intravenously and function similarly to red blood cells in the blood's circulation. When gas bubbles are subjected to general frequency ultrasound pulses, their diameters can vary, resulting in a powerful echo from the perfused tissue area.
The echogenicity and soft tissue surrounding of gasses differ greatly. As a result, utilizing microbubble contrast agents for ultrasonic diagnosis enhances the ultrasound reflection or backscattering, resulting in a distinctive echocardiogram with increased contrast.
US Microbubbles/Ultrasound Contrast Agents Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 1.87 billion
Largest Segment
cardiovascular diseases
Fastest Growth
cardiovascular diseases
Growth Rate
4.00% CAGR
To get more reports on the above market click here to Buy The Report
Global Microbubbles/Ultrasound Contrast Agents Market is segmented by Disease Area, Application, End Use, and region. Based on Disease Area, the market can be segmented into Cardio-vascular, Abdominal, Others. Based on Application, the market is segmented into Diagnostic imaging, Drug delivery, Others. Based on End-Use , the market is segmented into Diagnostic centers, Hospitals, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Disease Area
Based on the Disease area, Due to an increase in the prevalence of various chronic cardiovascular diseases, an increase in the demand for microbubbles in echocardiography imaging procedures, an increase in the mortality rate associated with heart attacks and strokes, and an increase in the demand for advanced diagnosis technologies, the cardiovascular diseases segment is anticipated to expand at a significant rate over the course of the forecast period.
Analysis by Application
Based on the application, The market for microbubbles and ultrasound contrast agents was dominated by molecular imaging.This was mostly because more and more molecular imaging techniques based on ultrasound were using microbubbles to accurately diagnose various diseases.The use of microbubbles in molecular imaging applications is further encouraged by the rising demand for targeted therapies, the need to monitor the biomarker status of vascular endothelium, the visualization of tumor vasculature, and the imaging of inflammation and ischemia-reperfusion injury zones.
To get detailed analysis on other segments, Request For Free Sample Report
Europe is anticipated to be dominant in the microbubbles/ultrasound contrast agents market. The growth of the global microbubbles/ultrasound contrast agents market in North America and Europe is driven by an increase in the geriatric population, an increase in the incidence and prevalence of chronic diseases, a well-established healthcare infrastructure, an increase in the cost of research and development, an increase in the adoption of advanced technologies, and higher healthcare expenditure in the regions. India and China are expected to dominate the microbubbles/ultrasound contrast agents market in Asia-Pacific during the forecast period due to their large patient bases, rising awareness, increased government efforts to improve public health, and developed healthcare infrastructure. Due to the increasing investments made by market participants in these regions, it is anticipated that the global market for microbubbles/ultrasound contrast agents will expand during the forecast period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Advancement of Technology to Bolster Market Growth
Restraints
Short Lifespan to Hinder Market Growth
Request Free Customization of this report to help us to meet your business objectives.
The major players covered in the microbubble contrast media market , while GE Healthcare is committed to providing a broad comprehensive portfolio of CM products that help meet your patient and procedural needs across a multitude of modalities.
Top Players Company Profiles
Recent Developments
Sky Quest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
According to our Global Microbubbles/Ultrasound Contrast Agents Market analysis, A large portion of North America's market share is primarily explained by the region's ageing population, rising chronic disease rates, well-developed healthcare system with a widespread network of suppliers and distributors, higher adoption of cutting-edge technologies, rising technological advancements in healthcare, and higher healthcare spending overall, particularly in the U.S.
But during the forecast period, the Asia-Pacific region is expected to grow the fastest. This is largely because of rising healthcare spending, better healthcare infrastructure, rising living standards with rising income of middle class population, growing healthcare awareness, and an aging population that will lead to an increase in chronic disease prevalence in Asian countries.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 1.87 billion |
Market size value in 2031 | USD 2.66 billion |
Growth Rate | 4.00% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
Recent Developments
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Microbubbles/Ultrasound Contrast Agents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Microbubbles/Ultrasound Contrast Agents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Microbubbles/Ultrasound Contrast Agents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Microbubbles/Ultrasound Contrast Agents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2055
sales@skyquestt.com
USA +1 351-333-4748